FDA approves Galderma’s Epiduo Gel treatment for acne

ROCKVILLE, Md. The Food and Drug Administration has approved a new acne treatment by Galderma Laboratories, the agency announced Wednesday.

The treatment, Epiduo Gel, is known generically as adapalene and benzoyl peroxide and is used to treat acne vulgaris in patients aged 12 and older.

FDA records indicate the agency approved it Monday.

Galderma, based in Lausanne, Switzerland, had not made a statement about the approval at midday Wednesday.